GLOW

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. These products are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. Purchasers must be 21 years or older. By purchasing, the buyer agrees to use these products in compliance with all applicable laws and regulations.

GLOW Blend Overview

The GLOW Blend combines three synthetic peptides studied for their roles in molecular signaling and pathway dynamics: GHK-Cu, BPC-157, and TB-500. Together, these peptides are investigated for their influence on angiogenesis, extracellular matrix remodeling, and systemic signaling pathways. In laboratory and preclinical models, the combination provides a platform for exploring effects in matrix integrity, vascular formation, and molecular resilience.

History

The concept of the GLOW Blend arises from decades of research into individual signaling peptides. GHK-Cu was first identified in human plasma in the 1970s and later studied for gene regulation and matrix remodeling activity. BPC-157 was characterized in the 1990s as a gastric protein fragment and has since been researched for angiogenic and structural processes. TB-500, derived from thymosin beta-4, traces its research lineage to thymus peptide studies and is recognized for its effects on molecular migration and angiogenesis. Combined, these peptides represent a convergence of experimental research lines.

GHK-Cu Structure

CAS: 49557-75-7
Molecular Formula: C₁₄H₂₄CuN₆O₄
Molecular Weight: ~403.9 g/mol

BPC-157 Structure

Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.5 g/mol
CAS: 137525-51-0

TB-500 Structure

Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: 4963.5 g/mol
CAS: 77591-33-4

Research Findings

The GLOW Blend, which combines GHK-Cu, BPC-157, and TB-500, has been studied across structural, epithelial, vascular, and systemic models. Research highlights its activity in collagen organization, molecular migration, angiogenesis, and molecular signaling. Together, these peptides complement one another by engaging pathways linked to matrix remodeling, pathway dynamics, and resilience in preclinical settings.

Key Areas of Research:

• Structural: Collagen, matrix, tendon/ligament
• Epithelial: Migration, matrix signaling, follicle dynamics
• Vascular: Angiogenesis, nitric oxide, formation
• Systemic: Signaling, viability, pathway dynamics

Together, these findings suggest broad experimental potential for the GLOW Blend across multiple biological pathways. By combining structural support, vascular formation, and epithelial remodeling with systemic signaling, the GLOW Blend provides a versatile platform for research into molecular dynamics, matrix characterization, and overall biological resilience in laboratory settings.

References

Maquart, F.X., Pickart, L., Laurent, M., et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Letters, 238(2), 343–346.

Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987.

Sikirić, P., et al. (1993). A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. Journal of Physiology (Paris), 87(5), 313–327.

Chang, C.H., et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774–780.

Smart, N., et al. (2007). Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature, 445(7124), 177–182.

Philp, D., et al. (2003). Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair. Wound Repair and Regeneration, 11(1), 19–24.

Bock-Marquette, I., et al. (2004). Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432(7016), 466–472.